Volume 21, Number 2—February 2015
Dispatch
Lagenidium giganteum Pathogenicity in Mammals
Figure 4
![Lagenidium giganteum from mammal experimental infection using Culex pipiens mosquito larvae. A) Composite of 2 photographs showing an instar 3 C. pipiens larvae infected with 1 of the 5 tested strains of L. giganteum recovered from dogs with lagenidiosis (MTLA01, type strain). Note the mycelioid structures emerging from the infected larvae (black arrows). B, C) Enlargements of the 2 white boxes in (A) showing details of the mycelioid structures emerging between the segments of the larvae. D, E)](/eid/images/14-1091-F4.jpg)
Figure 4. Lagenidium giganteum from mammal experimental infection using Culex pipiens mosquito larvae. A) Composite of 2 photographs showing an instar 3 C. pipiens larvae infected with 1 of the 5 tested strains of L. giganteum recovered from dogs with lagenidiosis (MTLA01, type strain). Note the mycelioid structures emerging from the infected larvae (arrows). B, C) Enlargements of the 2 white boxes in (A) showing details of the mycelioid structures emerging between the segments of the larvae. D, E) Aggressiveness of the invading mycelioid structures (arrows) within the body of C. pipiens larvae.
1These authors contributed equally to this article.
Page created: January 20, 2015
Page updated: January 20, 2015
Page reviewed: January 20, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.